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Autosomal-dominant sensorineural hearing loss is genetically heterogeneous, with a phenotype closely resembling presbycusis, the
most common sensory defect associated with aging in humans. We have identiﬁed SLC17A8, which encodes the vesicular glutamate
transporter-3 (VGLUT3), as the gene responsible for DFNA25, an autosomal-dominant form of progressive, high-frequency nonsyn-
dromic deafness. In two unrelated families, a heterozygous missense mutation, c.632C/T (p.A211V), was found to segregate with
DFNA25 deafness and was not present in 267 controls. Linkage-disequilibrium analysis suggested that the families have a distant com-
mon ancestor. The A211 residue is conserved in VGLUT3 across species and in all human VGLUT subtypes (VGLUT1-3), suggesting an
important functional role. In the cochlea, VGLUT3 accumulates glutamate in the synaptic vesicles of the sensory inner hair cells (IHCs)
before releasing it onto receptors of auditory-nerve terminals. Null mice with a targeted deletion of Slc17a8 exon 2 lacked auditory-nerve
responses to acoustic stimuli, although auditory brainstem responses could be elicited by electrical stimuli, and robust otoacoustic emis-
sions were recorded. Ca2þ-triggered synaptic-vesicle turnover was normal in IHCs of Slc17a8 null mice when probed by membrane
capacitancemeasurements at 2 weeks of age. Later, the number of afferent synapses, spiral ganglion neurons, and lateral efferent endings
below sensory IHCs declined. Ribbon synapses remaining by 3months of age had a normal ultrastructural appearance.We conclude that
deafness in Slc17a8-deﬁcient mice is due to a speciﬁc defect of vesicular glutamate uptake and release and that VGLUT3 is essential for
auditory coding at the IHC synapse.Introduction
Age-related hearing impairment, or presbycusis, is the
most common sensory disorder in older individuals, with
prevalence increasing with age.1 Both genetic factors and
environmental factors such as noise exposure inﬂuence
the development of presbycusis.2,3 Although a remarkable
number of genes responsible for hereditary hearing impair-
ment have been identiﬁed in recent years, a signiﬁcant
number of genes associated with mapped deafness loci still
await discovery.4 The dominant (DFNA) loci represent
interesting candidates for presbycusis, because the hearing
loss associated with these loci is typically delayed-onset
and progressive, and with few exceptions, predominantly
affects high frequencies. We previously mapped one such
locus, DFNA25 (MIM 605583), to chromosome 12q21-
q24.5
Molecular genetic studies of mutant mice and of hu-
mans with hereditary hearing loss have contributed to
our understanding of the unique properties of the afferent
synapse of cochlear inner hair cells.6,7 Bassoon (MIM
604020) is a presynaptic scaffolding protein that is
required to anchor the ribbon at the presynaptic active278 The American Journal of Human Genetics 83, 278–292, Augustzone of the sensory inner hair cell (IHC) synapse and for
synchronous signaling to the auditory nerve.8 Bassoon
mutant mice show reduction of the presynaptic readily
releasable pool of vesicles and impaired synchronous and
sound-evoked activation of spiral ganglion neurons. Oto-
ferlin (MIM 603681), a protein encoded by the OTOF
gene, is essential for the late step of synaptic-vesicle exocy-
tosis and may act as the major Ca2þ sensor that triggers
membrane fusion at the IHC ribbon synapse.9 Mutations
in OTOF are responsible for DFNB9 (MIM 601071) deaf-
ness, which is characterized by profound hearing loss
with documentation of preserved outer hair cell (OHC)
function as measured by otoacoustic emission (OAE) in
some patients.10,11
Very recently, Seal et al.12 identiﬁed another key compo-
nent of the IHC synapse, the vesicular glutamate trans-
porter-3 (VGLUT3 [MIM 607557]), which is encoded by
the SLC17A8 gene and transports the neurotransmitter
into synaptic vesicles before it is released into the synaptic
cleft. The genetic deletion of Slc17a8 in mice results in pro-
found deafness because of the lack of glutamate release.
Because SLC17A8 maps within the DFNA25 interval, we
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a mouse with a targeted deletion of Slc17a8 exon 2.13 Here,
we provide the ﬁrst evidence that a glutamate-transmis-
sion deﬁcit is directly responsible for human sensorineural
deafness, DFNA25, because of a mutation of SLC17A8, seg-
regating in two families. Although Slc17a8/mice exhibit
no response to sound, electrical stimulation applied to the
round-window membrane elicits clear auditory brainstem
responses. In addition, we demonstrate that IHC presynap-
tic function and morphology are intact up to the stage of
transmitter release after vesicle fusion, making Slc17a8/
mutant mice an excellent model to test therapeutic inter-
ventions in the inner ear.
Subjects and Methods
Human Subjects
These studies were approved by the Institutional Review Boards of
the University of Michigan (IRBMED) and the University of Iowa.
Phenotype and Mapping of DFNA25
The DFNA25 locus was mapped in an American family (family 1)
of Czech descent segregating autosomal-dominant, progressive,
high-frequency sensorineural hearing loss.5 The DFNA25 interval
as deﬁned by key recombination events spanned 20 cM and
14.3 Mb on chromosome 12q21-q245 and includes more than
60 genes, including SLC17A8 (UCSC Genome Browser). Penetrance
was shown to be age dependent and possibly also dependent on
the sex of the parent of origin.14
Iowa Family 1490, an American family of German descent, seg-
regated a similar type of high-frequency, autosomal-dominant
progressive hearing loss. A genome-wide linkage analysis was
performed as previously described15 and identiﬁed a locus on
12q21.2-q24.21 deﬁned by markers D12S326 and D12S79, span-
ning 38.9 cM, with a maximum LOD score of 3.91 at q ¼ 0 for
D12S78. In both families, hearing loss appeared to be nonsyn-
dromic, without a history of seizure disorders or other neurologic
dysfunction in affected family members.
Sequencing SLC17A8 from Human Genomic DNA Samples
DNA sequencing of all 12 coding exons and intron-exon junctions
was performed in four DNA samples from individuals in family 1
(three affected and one unaffected) and one affected individual
from family 1490. In addition, ﬁve DNA samples from individuals
(three affected and two unaffected) in an unrelated family (family
63) with nonsyndromic, dominant, progressive, high-frequency
hereditary hearing impairment were assayed. Primers for polymer-
ase chain reaction (PCR) were designed with the Primer 3.0 pro-
gram (Table S1 available online). PCR was done with Failsafe
(Epicenter Biotechnologies, Madison,WI, USA) or Bioline reagents
(Bioline, Taunton, MA, USA) according to the manufacturer’s
instructions. Standard thermocycling conditions were used with
50C–70C annealing temperatures and 30 s extension for 35 cy-
cles. PCR products were puriﬁed with the QiaQuick DNA extrac-
tion kit (QIAGEN, Valencia, CA, USA) and sequenced by dye-ter-
minator cycle sequencing on a 3730xl DNA analyzer (Applied
Biosystems, Weiterstadt, Germany) at the University of Michigan
DNA Sequencing Core or a 3130xl Genetic Analyzer (Applied
Biosystems) at the Molecular Otolaryngology Research Laboratory
with the manufacturer’s recommended reagents and software. Se-
quence data were compared to reference sequences NM_139319
(mRNA) and NP_647480 (protein) with Lasergene (DNAStar, Mad-
ison, WI, USA).The AmAssaying the Mutation for Segregation in the Families
and Presence in Controls
The presence of the c.632T/Cmutation was assayed by sequenc-
ing exon 5 in remaining available DNA samples (17 affected, 19
unaffected, 9 unknown status, and 8married-in spouses) in family
1 and in controls. A total of 267 unrelated controls were sequenced
of which 90 were from the DNA Polymorphism Discovery
Resource Panel, 99 were from the Caucasian North American
Panel, and 78 were from Human Variation Panels, consisting of
Northern European (ten samples), Czech (ten samples), African
American, Mexican, Southeast Asian, South American, Middle
Eastern, South African, Ashkenazi Jewish, Chinese, and North
African panels (Coriell Cell Repositories, Camden, NJ, USA).
For family 1490, the presence of the c.632T/C mutation was
determined by KpnI (New England Biolabs, Ipswich, MA, USA)
restriction digest of exon 5 in remaining available DNA samples
(seven affected, ﬁve unaffected, and ﬁve married-in spouses).
Conservation Analysis
Amino acid sequences representing exons 5 and 6 of select pro-
teins from the VGLUT protein family in H. sapiens (VGLUT1
[MIM 605208], VGLUT2 [MIM 607563], and VGLUT3), R. norvegi-
cus, and M. musculus and homologous proteins in C. elegans and
D.melanogasterwere obtained from theNCBI database and aligned
with ClustalX2 software.
Identification of Previously Unreported STRs and SNPs
We identiﬁed short tandem repeats (STRs) and single-nucleotide
polymorphisms (SNPs) not previously reported by searching
sequences from bacterial artiﬁcial chromosomes mapping to the
region of the SLC17A8 gene with Tandem Repeats Finder software.
Primer design and PCR for screening newly identiﬁed STRs was
done as described above for SLC17A8 exon primers. PCR product
was separated by polyacrylamide gel electrophoresis and detected
with silver staining. Primer design and PCR for SNP screening was
also done as described above for SLC17A8 exon primers, and PCR
products were analyzed by restriction digests. Restriction enzymes
for screening SNPs were used according to the manufacturer’s
instructions (New England Biolabs) and are as follows: rs79703820
with BsrI; rs11110349 with AseI; rs7485480 with DdeI; rs11568544
with NdeI; rs11110390 with NheI; and rs35735 with BstEII.
Haplotype Analysis
Haplotype analysis was done with STRs and single nucleotide
SNPs (Table S2). Primers to amplify previously reported STRs
were designed on the basis of reports (NCBI) and ﬂuorescently
labeled. PCR was done with AmpliTaq Gold polymerase and
buffers (Applied Biosystems) according to the manufacturer’s
instructions, and products were evaluated on a 3130xl Genetic
Analyzer (Applied Biosystems). Data analysis was performed
with GeneMarker software (Softgenetics, State College, PA, USA),
and haplotype reconstruction was done with custom-made
GeneScreen software (Itty Bitty Computers, San Jose, CA, USA).
Animals
The care and use of animals followed the animal-welfare
guidelines of the Institut National de la Sante´ et de la Recherche
Me´dicale (Inserm), and was approved by the Ministe`re Franc¸ais
de l’Agriculture et de la Peˆche (authorization number A 3417231).
All efforts were made to minimize the number and suffering of the
animals used.
Generation of the Slc17a8/ Mice
The entire procedure to generate the Slc17a8 knockout mice was
performed by the Institut Clinique de la souris (Illkirch, France).erican Journal of Human Genetics 83, 278–292, August 8, 2008 279
In brief, the null mutation in the Slc17a8 mouse gene, located on
chromosome 10, was created by homologous recombination.13
Removal of exon 2, after insertion of the targeting construct, intro-
duced a stop codon into exon 3 in frame with exon 1, resulting in
a complete loss of allele function. Consequently, mutant mice no
longer expressed Slc17a8 mRNA. All experiments were performed
with F2 wild-type and homozygous littermates derived from cross-
ing F1 heterozygous Slc17a8þ/ mice (129/Sv 3 C57BL/6). Mice
were identiﬁed by PCR analysis of tail DNA with three primers
located in intron 2–3 of the Slc17a8 gene or in the neomycin
cassette.
Animal Surgery
Animals were anaesthetized by an intraperitoneal injection of
a mixture of Rompun 2% (3 mg/kg) and Zoletyl 50 (40 mg/kg).
Both pinna were severed to facilitate the insertion and placement
of the distortion product otoacoustic emissions (DPOAEs) probe.
A retroauricular incision of the skin was performed on both sides,
and the bulla tympani were opened to expose the round windows.
Distortion Product Otoacoustic Emission Recordings
DPOAEs were recorded in the external auditory canal with an
ER-10C S/N 2525 probe (Etymotic Research, Elk Grove Village,
IL, USA) consisting of two emitters and one microphone. The
two primary tones were generated, and the distortion was pro-
cessed by the Cubdis system HID 40133DP (Mimosa Acoustics,
Champaign, IL, USA). The probe was self-calibrated for the two
stimulating tones before each recording. The two tones were
presented simultaneously, sweeping f2 from 0.5 kHz to 20 kHz
by quarter octave steps, and maintaining the f2/f1 ratio constant
at 1.2. The primary intensities of f2 and f1 were set at 60 dB and
55 dB SPL (ref. 2 3 105 Pa), respectively. For each frequency,
the cubic distortion product (2f1-f2) and the neighboring noise
magnitudes were measured and expressed as a function of f2.
Data are expressed as means5 standard error of the mean (SEM).
Recording of Cochlear- and Auditory-Nerve Potentials
The acoustical stimuli were generated by an arbitrary function
generator (type 9100R; LeCroy Corporation, Chestnut Ridge, NY,
USA), consisting of 9 ms tone bursts with a 1 ms rise and fall
time delivered at a rate of 10/s. Tone bursts were passed through
a programmable attenuator and delivered to the animal by a JBL
075 loudspeaker (James B. Lansing Sound, Los Angeles, CA, USA)
in a calibrated free ﬁeld. Cochlear potentials were obtained via a
silver electrode placed on the round window and then ampliﬁed
(32000) by a Tektronix (TM 503) differential ampliﬁer and digita-
lized (50 kHz sampling rate, with a 12-bit dynamic range and 1024
samples per burst), averaged 256 times, and stored on a computer
(Dell Dimensions, Austin, TX, USA). This signal was then digitally
ﬁltered either with a low-pass ﬁlter (cutoff frequency 3.5 kHz) to
display the compound action potential (CAP) and the summating
potential (SP) or with a band-pass ﬁlter centered on the frequency
of stimulation with a 4 kHz span to display the cochlear micro-
phonic (CM). We obtained intensity-amplitude functions of these
potentials at each frequency tested (2, 4, 6, 8, 10, 12, 16, 20, 26, 32,
and 64 kHz) by varying the intensities of the tone bursts from 0 to
100 dB SPL, in 5 dB steps. The CAP, SP, and CM thresholds were
deﬁned as the minimum sound intensity necessary to elicit
a clearly distinguishable response.
Electrical Stimulation of the Auditory Nerve
Electrical stimulation consisted in 25 ms rectangular pulses of alter-
nate polarity delivered at a rate of 20/s by a custom-made DC stim-
ulator. The intensity of the pulses was graded from 100 mA to 2mA
by 100 mA steps. Stimuli were delivered through a pair of electrodes
placed respectively on the round window and in the neighboring280 The American Journal of Human Genetics 83, 278–292, Augustmuscles. To insure that the electrical pulses directly activated
cochlear spiral ganglion neurons, we applied a droplet of artiﬁcial
perilymphcontaining10 mMofNa2þ channel blocker tetrodotoxin
(TTX) into the round-windowniche. Auditory brainstem responses
(ABRs) were recorded before and 30min after TTX application. The
artiﬁcial perilymph solution had the following composition: 137
mMNaCl, 5 mM KCl, 2 mMCaCl2, 1 mMMgCl2, 1 mMNaHCO3,
11 mM glucose, and 10mMHEPES. The pHwas 7.4 and the osmo-
larity was maintained at 300 mOsm/kg H2O.
Brainstem-Response Recordings
Brainstem-evoked responses to either acoustical stimulation of the
ear or to electrical stimulation of the cochlear nerve were differen-
tially recorded by needle electrodes placed subcutaneously respec-
tively at the vertex and at base of the pinna, whereas the ground
electrode was placed in the muscles of the posterior leg. The phys-
iological signal was ampliﬁed 100,000 times by a Grass P5 series
ampliﬁer (Grass Instruments, Quincy,MA,USA), digitalized (50 kHz
sampling rate, with a 12-bit dynamic range and 1024 samples per
burst), and averaged 1000 times (Dell Dimensions).
Patch-Clamp Recordings of Ca2þ Currents and Membrane Capacitance
The animals were maintained according to the animal-welfare
guidelines of the University of Goettingen and the State of Lower
Saxony. After cervical dislocation of mice (postnatal day 12 [P12]
to 18 [P18]), IHCs of the apical coil of freshly dissected organs of
Corti were patch-clamped at their basolateral face at room tem-
perature in perforated-patch conﬁguration as described previ-
ously.16,17 The pipette solution for perforated-patch recordings
contained the following: 130 mM Cs-gluconate, 10 mM tetra-
ethylammonium-Cl (TEA-Cl), 10 mM HEPES, 1 mM MgCl2, and
10mM4-Aminopyridine (4-AP) as well as 250 mg/ml amphotericin
B. The extracellular solution contained the following: 105 mM
NaCl, 35 mM TEA-Cl, 2.8 mM KCl, 1 mM MgCl2, 10 mM HEPES,
2 mM CaCl2, 1 mM CsCl, and 10 mM D-glucose. Solutions were
adjusted to pH 7.2 and had osmolarities between 290 and 310
mOsm/kg H2O. All chemicals were obtained from Sigma (St. Louis,
MO, USA), with the exception of CsOH (Aldrich, Milwaukee, WI,
USA) and amphotericin B (Calbiochem, La Jolla, CA, USA). Ca2þ
current integrals were calculated from the total depolarization-
evoked inward current, including Ca2þ tail currents after P/10
leak subtraction (i.e., from the start of the depolarization step to
1.5 ms after the end of the depolarization step). Cells that dis-
played amembrane current exceeding30 pA at87mVwere dis-
carded from the analysis. No series resistance (Rs) compensation
was applied; however, recordings with Rs > 30 MU were discarded
from the analysis. Current was low-pass ﬁltered at 4 kHz and sam-
pled at 10 kHz for capacitance measurements and at 40 kHz for
recordings of Ca2þ current-voltage relationships. All voltages
were corrected for the liquid junction potential between pipette
and bath (calculated at 16.9 mV).
Capacitance Measurements
Membrane capacitance (Cm) was measured with the Lindau-Neher
technique18 implemented in the software-lockin module of Pulse
(HEKA Elektronik, Lambrecht, Germany) combined with compen-
sation of pipette and resting cell capacitances by the EPC-9 (HEKA
Elektronik) compensation circuitries. A 1 kHz, 70mV peak-to-peak
sinusoid was applied about the holding potential of 87 mV. DCm
was estimated as the difference of the mean Cm over 400 ms after
the end of the depolarization (the initial 250 ms was skipped) and
themean prepulse capacitance (400 ms). Mean DCm and Ca
2þ cur-
rent estimates present grand averages calculated from the mean
estimates of individual IHCs. Data analysis was performed with
Igor Pro software (WaveMetrics, Lake Oswego, OR, USA).8, 2008
All the functional data (cochlear potentials, brainstem re-
sponses, distortion product otoacoustic emissions, and patch-
clamp recordings) are expressed as means5 SEM.
Light-Microscopic Evaluation of Slc17a8
Deletion in the Cochlea
The immunocytochemistry was performed on whole-mount prep-
arations of cochleas from knockout (n ¼ 18) and wild-type (n ¼
13) mice. The mice were decapitated under deep anesthesia (pen-
tobarbital 50 mg/kg), and their cochleas were removed from the
temporal bone and ﬁxed 1 hr in 4% paraformaldehyde diluted
in PBS (4C); afterward, they were dissected in PBS and immuno-
cytochemically processed as whole mounts.
The cochleas were rinsed 33 8 min in PBS, preincubated 1 hr in
30% normal goat or donkey serum (depending on the species of
the secondary antibodies) and 0.3% Triton X-100, and incubated
overnight at 4C in primary antibodies diluted in PBS containing
1% normal serum. They were then rinsed in PBS (3 3 8 min) and
incubated for 2 hr in ﬂuorescently labeled secondary antibodies.
They were ﬁnally rinsed in PBS (3 3 8 min), mounted in Mowiol,
and examined with the Zeiss LSM510 Meta or the BioRad
MRC1024 laser-scanning confocal microscope of the Montpellier
RIO Imaging IURC facility (Montpellier, France). The ﬂuorescence
emissions were collected sequentially in order to minimize bleed-
through between the emitted ﬂuorescences.
The three following pairs of primary antibodies were used:
RIBEYE (CtBP2)/GluR2 or GluR2/3 and synaptophysin/parvalbu-
min. We used a mouse monoclonal anti-CtBP2 IgG1 antibody
that recognizes both the B-domain of RIBEYE, a component of pre-
synaptic ribbons, and the transcriptional corepressor CtBP2 at a
dilution of 1:150-1:500 (BD Biosciences, San Diego, CA, USA).
RIBEYE and CtBP2 are alternate protein products of the CTBP2
(MIM 602619) gene locus, and their sequences differ by only the
ﬁrst 20 N-terminal amino acids.19 This antibody is now routinely
used to label IHC presynaptic ribbons in the cochlea.8,20,21
AMPA (alpha-amino-3hydroxy-5-methyl-4-isoxazole proprionic
acid) receptors were located with a mouse monoclonal IgG2a anti-
body raised against its GluR2 (ionotropic glutamate receptor-2)
subunit (clone 6C4, 1:200, Millipore, Temecula, CA, USA) and
a rabbit polyclonal antibody raised against the C terminus of the
GluR2/3 subunits (1:200, Millipore). This latter antibody has
been fully characterized22 and is widely used in the cochlea to
localize these subunits.8,23,24 The speciﬁcity of the monoclonal
antibody has been previously assayed with radioimmunoassay,
western blots, and immunocytochemistry for identiﬁcation
of GluR1- to GluR7-transfected human embryonic kidney
(HEK293) cells.25 In addition, this antibody has been used in the
cochlea to detect GluR2 in the maturing organ of Corti.26,27 It is
an optimal antibody to follow the lateral mobility of GluR2-con-
taining AMPA receptors to and from synaptic sites in rat-cultured
hippocampal neurons.28
As in earlier experiments,26,29,30 IHCs were immunolabeled
for the calcium-binding protein parvalbumin, and lateral oli-
vocochlear (efferent) ﬁbers were labeled for the synaptic-vesicle
transmembrane protein synaptophysin. The mouse anti-synapto-
physin (clone SVP-38, 1:500, Sigma) and the goat anti-parvalbu-
min (1:500, Swants, Bellizona, Switzerland) primary antibodies
were revealed with donkey secondary antibodies against mouse
IgGs and goat IgGs, respectively conjugated to Alexa 488 and
Alexa 647 (1:500, Invitrogen, Eugene, OR, USA). Anti-RIBEYE
(CtBP2) and anti-GluR2 mouse primaries were detected with
goat secondary antibodies against mouse IgG1 and IgG2a, respec-
tively conjugated to Alexa 488 and Alexa 568 (Invitrogen), at aThe Amedilution of 1:500. Anti-GluR2/3 rabbit and anti-RIBEYE (CtBP2)
mouse primaries were detected with goat secondary antibodies
against rabbit and mouse IgGs, respectively conjugated to Alexa-
488- and Alexa-568-labeled secondary antibodies (Invitrogen,
1:200) for 2-week-old animals.
Negative controls were carried out by omitting the primary an-
tibodies in the ﬁrst incubation step or by substituting them with
IgGs. In addition, we further assayed the species or isotype speci-
ﬁcity of the secondary antibodies. The sections were incubated
with only one primary antibody, then secondary antibodies. In
all the cases, only one speciﬁc ﬂuorescence was observed.
Whole-mount preparations of wild-type (n ¼ 4) and Slc17a8/
(n¼ 4) cochleas were immunostained for parvalbumin and synapto-
physin. The entire image of the inner spiral bundle from the basal
and the medial turns were acquired at the confocal microscope.
The whole stacks of images were then processed with ImageJ
(Wayne Rasband), median-ﬁltered, and 3D reconstructed. The
quantiﬁcation was done with the particle analysis plug-in on the
optical sections in which the synaptophysin-immunoreactive
endings did not overlap. The quantitative data were expressed as
the percentage of synaptophysin-positive endings per mm length
of the inner spiral bundle. The Student’s t test was used for the sta-
tistical analysis of the data.
Ultrastructural Evaluation of the Slc17a8 Gene
Deletion in the Mouse Cochlea
Themouse cochleas were dissected as described above and ﬁxed in
2.5% glutaraldehyde in 0.1 M (pH 7.3) phosphate buffer. They
were then processed for either scanning (SEM) or transmission
(TEM) electron microscopy. For SEM, two cochleas from two
Slc17a8/ mice were used. The otic capsule was dissected out,
and the stria vascularis, tectorial, and Reissner’s membranes were
removed. After rinsing in phosphate buffer (0.2 M, pH 7.3), the
samples were dehydrated in a graded series of ethanol (30%–
100%), critical-point-dried in CO2, coated with gold palladium,
and observed with a Hitachi S4000 microscope.
For TEM, both wild-type (n ¼ 3) and Slc17a8/ (n ¼ 6) cochleas
were used. The cochleas were postﬁxed in a 2% aqueous solution
of osmium tetroxide for 1 hr, rinsed in buffer, dehydrated in
a graded series of ethanol (30%–100%), and embedded in Epon
resin. Thin (8 mm) transverse sections were cut from the basal
turn and observed with light microscopy to have a gross morpho-
logical survey of the specimens. Then, ultra-thin sections (100 nm)
were performed, mounted on formvar-coated or mesh grids,
stained with uranyl acetate and lead citrate, and observed with
a Hitachi 7100 microscope.
The synaptic ribbons present at the presynapse between the af-
ferent dendrites of type I ganglion neurons and the IHCs were
counted with TEM on transverse sections of the organ of Corti
in both wild-type (n ¼ 3 cochleas) and Slc17a8-deﬁcient (n ¼ 6
cochleas) mice. A total of 18 IHCs were investigated in the wild-
type animals, and 30 IHCs were investigated in the Slc17a8-deﬁ-
cient ones. The synaptic ribbons were then classiﬁed into two
groups corresponding to normal and atypical structures, and the
proportion of synaptic ribbons in each group was calculated for
the wild-type and Slc17a8-deﬁcient mice. A single organelle at-
tached to the presynaptic membrane and showing a circular or
oval outline with a central electron-dense body% 500 nm and sur-
rounded by synaptic vesicles was deﬁned as normal. All other
types were considered atypical.
Measurements of vesicle outer diameter were performed in 16
normal ribbons in the wild-type and in 19 normal ribbons in
the Slc17a8-deﬁcient mice with the camera (AMT XR611)rican Journal of Human Genetics 83, 278–292, August 8, 2008 281
software on digitized images of synaptic ribbons taken at a magni-
ﬁcation 3 150,000. The number of vesicles surrounding the cen-
tral dense body was compared between the wild-type and
Slc17a8-deﬁcient mice from seven normal ribbons in each strain.
Results are presented as the number of vesicles present on both
sides of the dense body reported to a 100 nm length. Results
were statistically compared with the Student’s t test and pre-
sented as mean 5 SEM.
Results
Human Studies
A Mutation in SLC17A8 Is Responsible for Human
Deafness DFNA25
DNA sequencing in family 1 and family 1490 revealed
a heterozygous nonsynonymous missense mutation, nu-
cleotide change c.632C/T in exon 5, leading to amino
acid change p.A211V, segregating with DFNA25 deafness
in both families (Figure 1). Moreover, the p.A211V muta-
tion was not found in 267 controls (534 chromosomes)
or in the dB SNP database. No other variations from the ref-
erence sequence were detected other than SNPs (Table 1
and Table S2).
Sequence comparison of VGLUT3 to related proteins
and across species demonstrates conservation of the
A211 residue in the three human vesicular gluta-
mate transporters (VGLUT1-3), vglut3 in mouse and rat,
Figure 1. c.632C/T Mutation in SLC17A8
Sequencing chromatogram from normal-hearing control (top)
shows the wild-type nucleotide C at position 632. The wild-type co-
don is GCA and codes for alanine. Sequencing chromatogram from
affected individual from family 1 (bottom) shows heterozygous
c.632C/T mutation (indicated by an arrow), leading to p.A211V
amino acid change. The codon containing the mutation is GTA
and the altered amino acid is valine.282 The American Journal of Human Genetics 83, 278–292, AugustC. elegans eat-4, and Drosophila vglut (Figure 2). Molecular
models suggest that residue A211 is in the cytoplasmic
short linker region between transmembrane domains 4
and 5.31 Thus, this residue may be facing the pore and
therefore could affect the entry of the glutamate ligand
from the cytoplasm to the pore of the transporter and
into the vesicle. While both alanine and valine have
hydrophobic R groups, the addition of a second methyl
group secondary to the substitution of valine for an
alanine may increase the steric hindrance.
Age-Dependent Penetrance of DFNA25 Deafness
Sequence results assaying for the p.A211V mutation in
DNA samples from all related individuals in the DFNA25
pedigree were consistent with the family 1 haplotype re-
sults previously described.5 In other words, individuals
who carried the portion of the haplotype common to
the affected encompassing SLC17A8 (between D12S1063
and D12S1607) were found to carry the p.A211V muta-
tion.
The phenotype of hearing loss varied in terms of sever-
ity, audiometric pattern, and age of onset among affected
individuals within the family, as previously described.14
To further characterize the age of onset, we carried out
a penetrance analysis to estimate the likelihood of a muta-
tion-positive individual manifesting hearing loss by a cer-
tain age, given that this analysis was not possible on the
basis of linkage analysis alone. There were 24 individuals
with the p.A211V mutation for whom audiological data
were available, of whom two were younger than age 20
at time of diagnosis. Penetrance was 77% (17/22) for those
aged 20 and older; 80% (16/20) for those aged 30 and
older; 83% (10/12) for those 40 and older; 86% (6/7) for
those aged 50 and older; and 75% (3/4) for those 60 and
older (Table S3). We did not screen for the mutation in
individuals younger than 20 years of age without hearing
loss.
SLC17A8 Mutation Screening in Other Subjects
Notably, there were three individuals with hearing loss
who were not worse than expected for their age and sex
and who were considered unaffected a priori to linkage
analysis by criteria previously described.5,14 These sub-
jects, whose hearing loss was consistent with presbycusis
and who did not carry the DFNA25 haplotype, tested neg-
ative for the p.A211V mutation. The p.A211V mutation
was not found in married-in spouses (with or without
age-related hearing loss) in family 1 or in subjects from
family 63.
Linkage-Disequilibrium Analysis
Linkage-disequilibrium analysis was performed by geno-
typing SNPs and STRs in the SLC17A8 region in family 1
and family 1490 (Table 1). There was a region of linkage
disequilibrium spanning approximately 36 kb, for which
the SNP genotypes were the same in both families. Interest-
ingly, the LD is conﬁned to SNPs within the gene but is not
conserved for the entire gene; the two families have two
different genotypes for rs11568544, 6 kb telomeric to the
mutation.8, 2008
Table 1. Linkage Disequilibrium Analyses comparing STR and SNP Haplotypes for Michigan Family 1 and Iowa Family 1490
Frequency of D Allele Family 1 Genotypes STR/SNP Location in SLC17A8 Mb Family 1490 Genotypes Frequency of D Allele
D W D W
3 6 D12S1063 97.223 5 4
6 6 D12S1706 97.392 8 6
4 4 D12S306 99.117 3 4
0.800 T T rs7970382 99.128 T T 0.8
2 3 AC026110.1 99.176 5 2
3 2 AC026110.2 99.238 3 2
0.217 T C rs11110349 Intron 1 99.278 T C 0.217
2 1 AC126308.1 Intron 1 99.298 2 1
0.737 G A rs7485480 Intron 2 99.305 G A 0.737
2 1 AC126308.2 Intron 2 99.308 2 1
T C c.632C/T
(p.A211V)
Exon 5 99.314 T C
0.672 A A rs11568544 Intron 6 99.319 G G 0.328
T T ss104807044a Exon 8 99.321 C C
3 3 AC126308.3 Intron 9 99.327 2 2
1 1 AC126308.4 99.359 1 1
0.317 T C rs11110390 99.399 T T 0.317
1 2 AC010200.1 99.431 5 7
1 1 AC010200.2 99.440 1 1
0.397 G T rs35735 99.475 T G 0.603
1 2 D12S1727 100.225 3 4
5 7 D12S1607 100.782 - -
2 2 D12S1030 101.448 4 1
‘‘D’’ indicates haplotype segregating with disease allele; ‘‘W’’ indicates haplotype segregating with wild-type allele in representative affected individuals.
Bold indicates the portion of D haplotype shared between families 1 and 1490. Dashes indicate genotype data not available.
a c.951T/C, p.Y317Y. T allele also found in family 63 and reported in AK_128319, NW_001838061.2, and NT_019546.15; C allele reported in NM_139319.Mouse Studies
Slc17a8 Deletion Does Not Induce Major Structural
Changes at IHC Afferent Synapses
We ﬁrst examined the overall morphology of the organ of
Corti in Slc17a8/ mice. Examination of the surface of
the organ of Corti with SEM revealed that Slc17a8/mice
display a full contingent of hair cells, except for a few scat-
tered missing IHCs (less than 1% of the total number of
IHCs) detected along the cochlear partition from base to
apex. The shape of the stereocilia of both types of hair cells
had a normal appearance (Figure 3A). Transverse light-mi-
croscopic sections of the organofCorti showed anormal as-The Ampectwithwell-opened tunnel ofCorti (Figure3B). Transmis-
sion electron microscopy (Figures 3C–3J) conﬁrmed that
both OHCs (Figure 3C) and IHCs (Figure 3D) had a healthy
appearance with a normal cytoplasmic content, well-de-
ﬁned organelles, and normal distribution of chromatin
within the nucleus. The basal pole of the OHCs was inner-
vated by large vesiculated efferent endings (axons ofmedial
efferent neurons) and small afferent (dendrites from type II
ganglionneurons, Figure 3E). Themidbasal part of the IHCs
was contacted by afferent dendrites (Figure 3F). Vesiculated
axonal endings probably originating from the lateral effer-
ent neurons were seen in the inner spiral bundle makingFigure 2. Conservation of Amino Acids of VGLUT3 Encoded by Exons 5 and 6
Amino acid sequence representing exons 5 and 6 of select proteins from the VGLUT protein family in H. sapiens, R. norvegicus, and
M. musculus, and homologous proteins in C. elegans and D. melanogaster were aligned in ClustalX2. Asterisks show identical residues
between the aligned sequences. An arrow indicates residue mutated in DFNA25 deafness.erican Journal of Human Genetics 83, 278–292, August 8, 2008 283
Figure 3. Slc17a8 Deletion Does Not
Induce Major Change at IHC-Afferent
Synapses
Electron (A and C–J) and light microscopy
(B) of the organ of Corti in the basal turn
of Slc17a8/ (A–F and H–J) and wild-
type (þ/þ, [G]) mice are shown.
(A) Surface of the organ of Corti observed
with SEM. The stereociliary bundles are
well organized in both the three rows of
OHCs and the single row of IHCs. However,
note the missing stereociliary bundle
(asterisk) in the IHC row. ‘‘p’’ stands for
pillar cells.
(B) Gross morphology of the organ of Corti
seen in transverse section. The organ of
Corti shows a normal appearance with well
opened tunnel of Corti (tC), one IHC, and
three OHCs. Note the presence of medial
efferent fibers (indicated by an arrowhead)
crossing the tunnel of Corti. The following
abbreviations are used: D, Deiters cells;
tm, tectorial membrane; and bm, basilar
membrane. (C)–(M) show TEM.
(C)A normal appearingOHC showingerected
stereocilia (indicated by an arrow), clear cy-
toplasm, a basal nucleus with peripherally
located chromatin, typical distribution of
mitochondria (indicated by arrowheads)
along the lateral wall of the cell and below
the nucleus. Note the efferent nerve ending
(e) onto the basal pole of the OHC.
(D) Normal appearing IHC with erected
stereocilia (indicated by an arrow), a clear
cytoplasm, and a nucleus centrally posi-
tioned with peripheral chromatin. Note
the nerve fibers underneath the IHC and
in contact with its basal pole (indicated
by arrowheads). The following abbrevia-
tions are used: pc, phalangeal cell; bc,
border cell; and ip, inner pillar cell.
(E) Typical innervation pattern at the basal
pole of an OHC showing a large efferent
ending and a smaller afferent bouton (a).
(F) Basal pole of an IHC contacted by several afferent dendrites (a). Note the presence of a vesiculated efferent fiber (e) synapsing
(indicated by arrowheads) with an afferent dendrite. ‘‘sc’’ stands for supporting cell.
(G–N) Structural variability of synaptic ribbons in IHCs from wild-type (G–J) and Slc17a8-deleted (K–N) mice. (G), (K), and (J) show nor-
mal synaptic ribbons. In (G) and (K), note the postsynaptic density (indicated by arrowheads) on the afferent bouton. (H)–(N) show
atypical synaptic organelles including very long (H and M) and ectopic (I and N) ribbons and accumulation of synaptic vesicles without
central electron-dense body (J).
(O) Proportion of normal versus atypical ribbons in wild-type (n ¼ 3 cochleas) and Slc17a8/ (n ¼ 6 cochleas) mice. Quantification was
done from 18 and 30 IHCs, respectively. Percents were calculated from 19 synaptic bodies in the wild-type and 23 in the Slc17a8/ mice.
(P) The left panel shows quantitative analysis of the outer diameter of vesicles surrounding normal synaptic ribbons seen in IHCs from
three wild-type mice (þ/þ) and six Slc17a8-deleted mice (/). A total of 16 synaptic ribbons were investigated in the wild-type mice
against 19 synaptic ribbons in the Slc17a8/ mice. A total number of 140 and 129 synaptic vesicles were measured in the wild-type and
the deleted mice, respectively. The right panel shows quantification of vesicles per 100 nm of central dense body in normal synaptic rib-
bons from wild-type mice (n¼ 7 ribbons) and Slc17a8-deleted mice (n¼ 7 ribbons). No significant difference was found. Scale bars in (A)
and (B) represent 10 mm, those in (C) and (D) represent 5 mm, those in (E) and (F) represent 1 mm, and those in (G)–(N) represent 100 nm.classical en-passant axodendritic synapses with afferent
ﬁbers (Figure 3F). Occasional efferent contacts were also
observed on IHCs (not shown).284 The American Journal of Human Genetics 83, 278–292, AugustThe presynaptic site of the IHC afferent synapse dis-
played ribbons of various shapes facing afferent boutons
(Figures 3G and 3H). Some ribbons showed classical8, 2008
structural organization (Figures 3G, 3K, and 3L), whereas
others had an atypical appearance (Figures 3H–3J, 3M,
and3N). Thenormal synaptic bodies had roundor oval out-
lineswith a centrally positioned dense body, surrounded by
vesicles and anchored to the presynaptic membrane. The
atypical organelles included very long (ranging from
500 to 850 nm; Figures 3H and 3M) or double synaptic
bodies (Figure 3N). A few synaptic ribbons were not located
at the presynaptic membrane but were found ﬂoating
within the IHC cytoplasm (Figures 3I and 3N). Occasional
accumulations of synaptic vesicles without detectable
central dense bodies were also seen either near the presyn-
apticmembrane (Figure 3J) or in ectopic positions. The typ-
ical postsynaptic density was seen on the afferent boutons
facing the presynaptic active zone (Figures 3G and 3K).
We performed a quantitative analysis to investigate the
proportion of normal versus atypical synaptic ribbons in
wild-type (n¼19 ribbons) and Slc17a8-deﬁcient (n¼23 rib-
bons) mice (Table S4). Formations lacking a central dense
body were not included in this analysis. Our results show
that the proportion of normal versus atypical synaptic
ribbons was similar, 69.23% versus 30.77%, as compared
to 72.73% versus 27.27% in wild-type and Slc17a8/
mice, respectively (Figure 3O). Measurements of the outer
diameter of synaptic vesicles surrounding normal ribbons
revealed no signiﬁcant difference in the size of vesicles
between the wild-type (140 vesicles from 16 ribbons) and
the Slc17a8/ mice (129 vesicles from 19 ribbons). The
mean diameter of vesicles was respectively 45.84 nm 5
0.86 and 47.82 nm5 1.53 (Figure 3P, left). Similarly, quanti-
ﬁcation of vesicles surrounding normal ribbons in wild-type
(n ¼ 7 normal ribbons) and Slc17a8/ mice (n ¼ 7 normal
ribbons) shows no signiﬁcant difference between wild-type
and mutant mice with a mean of 4.56 vesicles5 0.29 and
4.84 vesicles 5 0.30 per 100 nm of dense body length,
respectively (Figure 3P, right).
Slc17a8 Deletion Causes a Slowly Progressing Loss of IHC
Synapses and Spiral-Ganglion Neurons
Studies in mice demonstrated that, of the three vesicular
glutamate transporters, only Vglut3 is selectively expressed
in the IHCs (Figure S1A and Seal et al.12). The deletion of
the Slc17a8 gene in mice abolished the Vglut3 expression
in the IHCs (Figure S1B) but did not affect the expression
of the presynaptic proteins such as cysteine-string protein
and synaptogyrin (Figures S1C and S1D).
We used immunoreactivities of RIBEYE/CtBP2 and
GluR2 to visualize the presynaptic ribbons and postsynap-
tic AMPA receptors at IHC synapses in 3-month-old mice.
No ﬂuorescence was observed in the negative controls.
Both immunoreactivities were juxtaposed in Slc17a8/
cochleas (Figure 4A). However, a lower density of ribbons
was seen as a consequence of the gene deletion. We thus
quantiﬁed their number in the wild-type and Slc17a8/
mice. Counting RIBEYE/CtBP2-positive dots per IHC
revealed that wild-type IHCs possessed 12.55 5 0.63 pre-
synaptic ribbons (Table S5A). The gene deletion induced
a signiﬁcant reduction (43.90%) in the number of immu-The Amenostained dots, leading to 7.04 5 0.53 ribbons per IHC
(Figure 4B). This is consistent with the signiﬁcant reduc-
tion (42%) observed in the number of spiral-ganglion neu-
rons in Slc17a8/ mice (Figures S2A–S2C and Table S5B).
No sign of degeneration was seen in the remaining
neurons. In fact, Slc17a8/ mice showed a low density
of spiral-ganglion neurons with a regular shape, clear cyto-
plasm, and round nucleus, surrounded by several rows of
myelin (Figures S2D–S2F).
Slc17a8 Deletion Reduced the Number of Lateral
Efferent Endings
We used the synaptophysin immunoreactivity to identify
presynaptic endings of lateral olivocochlear efferents form-
ing axodendritic synapses with the dendrites of spiral-gan-
glion neurons. A striking consequence of the Slc17a8 gene
deletion was a strong decrease of the synaptophysin
immunoreactivity in the inner spiral bundle in the basal
turn of the cochleas (Figure 4C). Counting synaptophysin-
immunoreactive endings along the inner spiral bundle of
thebasal andmedial turns (TableS5C) showed that thenum-
ber of the lateral efferent endings was reduced by 69.5% in
the basal turn and 43.3% in the medial turn (Figure 4D).
Slc17a8 Deletion Does Not Affect the Transduction Mechanism
We thenmeasured cochlear responses fromanelectrode ap-
posed onto the round-window membrane, and DPOAEs
were recorded in the external ear canal (see Figure 5). Wild-
type Slc17a8þ/þ (n¼ 10) and Slc17a8þ/ heterozygousmice
(n¼ 10) showed the classical sound-evoked CAP waveform
in responses to all sound stimulation from 2 to 64 kHz with
thresholdsbetween20and45dB soundpressure level (SPL).
In contrast, the Slc17a8/ (n ¼ 12) littermates showed
no visible CAP responses, even for stimulus intensities of
100 dB SPL (Figures 5A–5C). Assessment of the functioning
of the transductionmechanismsof sensoryhair cells showed
no signiﬁcant difference in CM and SP amplitude-intensity
functions in responses to 12 kHz tone-bursts among in
Slc17a8þ/þ, Slc17a8þ/, or Slc17a8/ mice (Figures 5D and
5E). Furthermore, DPOAEs were not signiﬁcantly different
in the wild-type and in the mutant mice, reﬂecting normal
outer hair cell function at all stimulus frequencies and
intensities studied (Figure 5F). Mechanoelectrical transduc-
tion of hair cells remained fully functional in the absence
of Slc17a8 as indicated by the receptor potentials (SP and
CM) of both IHCs and OHCs.
Slc17a8 Deletion Does Not Affect Synaptic-Membrane Turnover
To determine whether the absence of Vglut3 impairs syn-
aptic-vesicle cycling, we probed the Ca2þ-triggered fusion
of IHC synaptic vesicles with patch-clamp measurements
of exocytic capacitance changes in 2-week-old mice
(Slc17a8/ and Slc17a8þ/þ). The Ca2þ currents of the
two genotypes were similar in terms of kinetics and voltage
dependence, but Slc17a8/ IHCs showed larger Ca2þ cur-
rent (Figure 6A). Fast exocytosis, mediated by the readily
releasable pool of vesicles and sustained secretion
(reviewed in Nouvian et al.7) were normal despite the ab-
sence of Vglut3 (Figures 6B and 6C). This ﬁnding indicates
that IHCs maintain synaptic-vesicle cycling even thoughrican Journal of Human Genetics 83, 278–292, August 8, 2008 285
Figure 4. Slc17a8 Deletion Reduced
the Number of IHC Synapses and Lateral
Efferent Endings
(A) Confocal microscopy of RIBEYE immu-
noreactivity through basal turn inner hair
cells of Slc17a8þ/þ and / mice. The
hair cell nuclei display the immunoreactiv-
ity to the CtBP2 transcription factor. The
RIBEYE-immunoreactive dots are seen at
the hair cell (IHC) bases in the Slc17a8/
mouse, although they are less densely
distributed than in the wild-type. The in-
serts show that in both mice, RIBEYE-
immunoreactive dots face GluR2 immuno-
reactive spots. The scale bar represents
15 mm.
(B) RIBEYE dots count in þ/þ and / co-
chleas (n ¼ 3 and 4 respectively) shows
a strong (43.90%) and significant (p ¼
9.17 3 108) decrease of the number of
immunoreactive dots at the IHC bases of
SLC17A8 / mice.
(C) Confocal microscopy through the basal
turn of Slc17a8þ/þ and / mice. IHCs are
labeled with parvalbumin (red), and lateral
efferent endings are labeled with synapto-
physin (green). Note the strong reduction
in the number of immunoreactive endings
in the Slc17a8/ mouse. The scale bar
represents 10 mm.
(D) Quantitative analysis of the number of
synaptophysin-immunoreactive endings
beneath IHCs from the basal and medial cochlear turns of wild-type (n¼ 4 cochleas) and Slc17a8/ (n¼ 4 cochleas) mice. The reduction
in the number of synaptophysin-immunoreactive endings is more pronounced in the basal turn (69.51% reduction) than in the medial
turn (43.26%).glutamate cannot be loaded and released. In line with
these results, immunostaining of afferent IHC synapses
(Figures 6D and 6E) for presynaptic ribbons (RIBEYE,
green) and postsynaptic glutamate receptors (GluR2/3,
red) revealed comparable numbers of ribbon-containing
afferent synapses from 2-week-old mice (12.3 5 0.3 for
Slc17a8þ/þ, n ¼ 76 IHCs of 5 mice, and 11.8 5 0.3 for
Slc17a8/, n ¼ 112 IHCs of 4 mice; P13-P17).
Preserved Auditory-Nerve Function in Slc17a8/ Mice
Next, we explored the functionality of the nerve by record-
ing ABRs evoked by electrical stimulation applied to the
round-window membrane. Whereas sound-evoked ABRs
were elicited only inwild-type and in Slc17a8þ/mice, elec-
trical stimulation evoked ABRs in Slc17a8/ mice as well
(Figures 7A and 7B). A slight reduction of ABR amplitude
in Slc17a8/ was noted in comparison with Slc17a8þ/þ
and Slc17a8þ/mice (Figures 7C and 7D), probably because
of the40% loss of spiral-ganglionneurons.We inhibited the
generation of the action potentials of the spiral-ganglion
neurons by applying 10 mM TTX into the round-window
niche. The lack of electrically evoked ABRs in the presence
of TTX demonstrated that electrical stimulation selectively
activated the spiral-ganglion neurons. Thus, the preserva-
tion of functional transduction pathways in the IHCs,286 The American Journal of Human Genetics 83, 278–292, Augusttogether with the response of spiral-ganglion neurons to
electrical stimulation, demonstrates that the profound
hearing impairment observed in Slc17a8/ mice results
from an IHC synaptic-transmission defect.
Discussion
Here, we identify the gene responsible for human autoso-
mal-dominant nonsyndromic DFNA25 deafness at the
12q21-q24 locus5 as SLC17A8, an 11 exon gene encoding
the vesicular glutamate transporter 3. To our knowledge,
this ﬁnding represents the ﬁrst mutation in a VGLUT asso-
ciated with human disease. The SLC17A subfamily of sol-
ute carrier membrane transport proteins includes VGLUTs
and other proteins such as sialin (SLC17A5) involved in
transport of organic anions.32
Expressivity and Penetrance
The expression of DFNA25 deafness is variable in terms of
onset and rate of progression, with an age-dependent pen-
etrance resembling an early-onset presbycusis.14 In general,
for family 1, penetrance increaseswith age; the apparent de-
crease in penetrance at age 60 probably reﬂects the small8, 2008
Figure 5. Slc17a8 Deletion Leads to a Profound Deafness, but Does Not Affect the Functioning of Cochlear Mechanotransduction
(A) Typical examples of averaged cochlear action potentials (CAPs) recorded from an electrode apposed onto the round-window membrane
for wild-type and Slc17a8/ mice. The potentials were recorded in response to 12 kHz tone bursts presented from 0 to 100 dB SPL.
Slc17a8þ/þ (n ¼ 12) and Slc17a8þ/ heterozygous mice (n ¼ 8, not shown) showed the classical sound-evoked N1-P1 CAP waveform
in responses to all sound stimulation. In contrast, the Slc17a8/ (n ¼ 12) littermates showed no visible CAP response, even for
high stimulus intensities. Note that the summating potential (SP), which reflect the functional state of the inner hair cells, remains intact
in Slc17a8/ mice.
(B) CAP audiograms for Slc17a8/, Slc17a8þ/þ and Slc17a8þ/ mice were obtained by plotting CAP thresholds as a function of the stim-
ulation frequency (2–64 kHz tone-bursts). Compared to Slc17a8þ/þ (black circles) and Slc17a8þ/ (open squares) mice, Slc17a8/ mice
(open circles) show no sound-evoked response at any stimulating frequency and intensity.
(C–E) Input-output functions of the CAP, SP, and cochlear microphonic (CM) evoked by a 12 kHz tone-bursts from 0 to 100 dB SPL in
Slc17a8/, Slc17a8þ/þ and Slc17a8þ/ mice. As shown in (C), Slc17a8/ mice displayed a complete abolition of CAP. The inset in
(C) shows a typical trace of averaged cochlear potentials evoked by 12 kHz tone bursts presented at 80 dB sound pressure level (SPL).
By contrast, normal SP (D) and CM (E) potentials were recorded in all animals tested.
(F) Recordings of distortion product otoacoustic emissions (2f1-f2) reflect the cochlear nonlinearity as a result of outer hair cell function.
No significant change was measured between Slc17a8/, Slc17a8þ/þ, and Slc17a8þ/ mice. The thick gray line indicates the background
noise level of the recording system in the absence of sound. Values are mean 5 SEM, and n indicates the number of animal tested.number of subjects ﬁrst ascertained at that age. Because
penetrance in family 1 was incomplete even in the seventh
decade of life,5 the DFNA25 candidate gene interval was
based on recombination events in affected individuals
only. Haplotype analysis of a second linked family (family
1490) did not reduce the size, and consequently, the
DFNA25 interval was quite large. Several candidate genes
in the interval have been sequenced without evidence
of pathologic mutations (S.E., T.A.S., and M.M.L., unpub-
lished data; J.M.V.R. and R.J.H.S., unpublished data).The AmeInterestingly, we previously found that several ‘‘carriers’’
(those who inherited the haplotype segregating with deaf-
ness but with normal hearing for age and sex) had in-
herited the haplotype from their fathers rather than their
mothers.14 We have previously excluded several deafness-
associated mitochondrial mutations14 as modiﬁers, but
other autosomal or mitochondrial modiﬁer genes cannot
be excluded. In addition, the phenotype may be inﬂu-
enced by environmental factors such as noise exposure
and smoking.33rican Journal of Human Genetics 83, 278–292, August 8, 2008 287
Figure 6. Ca2þ-Triggered IHC Exocyto-
sis Is Not Impaired by the Lack of Vglut3
(A) Ca2þ current steady-state I/V relation-
ships of Slc17a8þ/þ (black) and Slc17a8/
(gray) IHCs from P12-18 mice. Steady-state
amplitude was measured as the average
over the last 5 ms of the 10 ms test pulse.
Statistical significant difference is indicated
by asterisks (p < 0.05, unpaired t test).
(B) Ca2þ current (ICa
2þ), membrane capac-
itance (Cm) low-pass filtered at 100 Hz,
series conductance (Gs), and membrane con-
ductance (Gm) traces (from top to bottom) of
representative Slc17a8þ/þ (black, P12) and
Slc17a8/ (gray, P13) IHCs elicited by
20 ms depolarization to the peak Ca2þ
current potential.
(C) Kinetics of exocytosis (DCm, top) and
corresponding Ca2þ current integrals (QCa2þ,
bottom) of Slc17a8þ/þ (black) and
Slc17a8/ (gray) IHCs. DCm were obtained
by multiple depolarizations of different
durations to peak calcium current potential
in each IHC and represent grand averages
calculated from the means of the individual
IHC. For Slc17a8þ/þ and Slc17a8/, respec-
tively, Rs ¼ 19.6 5 0.7 MU and 18.7 5
0.9 MU; resting membrane capacitance ¼
8.95 0.2 pF and 8.95 1.4 pF, and resting
current at holding potential (87 mV) ¼
17.75 1.1 pA and17.95 1.1 pA. Statis-
tically significant difference is indicated by
asterisks (p< 0.05, unpaired t test).
(D) Representative projections of confocal sections from P14 Slc17a8þ/þ and P17 Slc17a8/ apical organs of Corti stained for GluR2/3
(red) and RIBEYE/CtBP2 (green). ‘‘n’’ stands for nucleus; scale bars represent 5 mm.
(E) Quantitative analysis of synapse-anchored ribbons per IHC identified as small RIBEYE-positive spots underneath the IHC nuclei
juxtaposing GluR2/3 immunofluorescence spots from P13-P17 mice.Linkage Disequilibrium
The HapMap project has identiﬁed large blocks of linkage
disequilibrium across the human genome (International
HapMapConsortium2007). In European populations, hap-
lotypeblocks ranging from<1 to173kbhavebeenreported,
with an averageminimum span of 18 kb.34 The 36 kb block
of LD surrounding the p.A211V mutation in the two fami-
lies is therefore well within the range of LD seen in the gen-
eral population. Finding the same haplotype surrounding
themutationargues for a common, althoughdistant, ances-
tor because the alternative hypothesis, that the identical
mutation evolved separately, appears to bemuch less likely.
Given the implied age of thismutation, it is likely that it will
be found in additional individuals with hearing loss, but
this mutation may be difﬁcult to recognize because of the
variability of the age of detection and rate of progression.
Selective Inner Hair Cell Dysfunction
Because Slc17a8/ null mice clearly demonstrate robust
OAEs, indicative of preserved OHC function, the question
arises as to whether OAEs are preserved in human partici-
pants with heterozygous missense SLC17A8 mutations as288 The American Journal of Human Genetics 83, 278–292, Augustwell. Data were available for two affected individuals in
family 1. One 68-year-old affected individual was found
to have absent transient-evoked OAEs and no repeatable
waveforms by ABR, consistent with moderate-severe to
severe sensorineural hearing loss.5 A 38-year-old affected
individual had absent DPOAEs and elevated pure tone
thresholds between 4 and 8 kHz (M.M.L., unpublished
data). The possibility that OAEs are preserved in hearing-
impaired participants at younger ages and lost secondarily,
as has been demonstrated for AUNA1 (MIM 609129) deaf-
ness35,36 and DFNB9 deafness,37 cannot be excluded.
Slc17a8 Deﬁciency Causes Profound Hearing
Loss in Mutant Mice
Glutamate is the major excitatory neurotransmitter at the
IHC afferent synapse.38 Before its exocytotic release, it
must be loaded into synaptic vesicles by proton-driven
membrane transporters.39,40 In contrast to the brain, in
which it is sparsely distributed and often associated with
other neurotransmitters,39–42 Vglut3 is strongly and selec-
tively expressed in cochlear IHCs (our present study and
Seal et al.12).8, 2008
Figure 7. Slc17a8 Deletion Preserves
the Integrity of the Auditory Nerve
(A) Typical auditory brainstem responses
(ABRs) evoked by sound stimulation or by
electrical stimulation applied via an elec-
trode apposed onto the round-window
membrane recorded in Slc17a8þ/þ mice.
The upper part of the figure shows super-
posed ABR traces evoked by a click pre-
sented at 50 dB SPL. Characteristic waves
(I to IV) are clearly seen. The middle part
of the figure shows ABR traces elicited by
round-window electrical stimulation of
1 mA in the same animal. Note the similar
pattern of ABR traces in both condition of
stimulation. No electrophysiological re-
sponse to sound or electrical pulses was re-
corded after round-window application of
10 mM Naþ channel blocker, TTX.
(B) No acoustical ABR response was seen in
Slc17a8/ mice whatever the intensity of
sound stimulation (top trace). In contrast,
this knockout mice shows clear electrically
evoked-ABRs (middle trace) that could be
abolished after injection of 10 mM TTX
into the cochlea (bottom trace).
(C) Shown are input-output functions of
ABRs wave I evoked by acoustical (gray
symbols) or electrical (black symbols)
stimulation in Slc17a8/ and Slc17a8þ/þ mice. Electrical ABRs amplitude is clearly reduced (black open circles) in Slc17a8/ mice.
Consistent with CAP data, no ABR could be evoked by sound stimulation in Slc17a8/ mice (gray open circles).
(D) The histogram represents the mean amplitude from 0 to 100 dB SPL sound stimulation and 0 to 2 mA electrical pulses for acoustically
evoked ABRs (aABRs; gray bar) and electrically evoked ABRs (eABRs; black bar) in Slc17a8þ/þ and in Slc17a8/ mice, respectively. No
response was recorded after cochlear injection of 10 mM TTX. Data presented are mean 5 SEM, and n indicates the number of animal
tested.Direct patch-clamp recordings of hair cells from single
postsynaptic boutons demonstrated the absence of synap-
tic transmitter release from the IHC at the ﬁrst synapse of
the auditory pathway.12 Our presynaptic capacitance mea-
surements indicated that Ca2þ-triggered synaptic-vesicle
turnover occurs independently of glutamate loading, and
such a ﬁnding is consistent with the normal cycling of syn-
aptic vesicles observed in Slc17a7 (which encodes Vglut1)
knockout mice.43 The observation of normal kinetics and
amounts of hair cell exocytosis in Slc17a8 knockout mice
demonstrates that even detailed synaptic properties are
unchanged in the absence of functional transmission.
The slight increase of the Ca2þ current in Slc17a8-deﬁcient
IHCs is currently unexplained but may reﬂect some adap-
tation. Hair cell function was also intact upstream from
Ca2þ-induced vesicle turnover as were presynaptic-trans-
duction mechanisms.
The normal afferent synaptogenesis of IHCs in Slc17a8
knockoutmice is consistent with ﬁndings in CaV1.3 (a sub-
unit 1.3 forming L-type voltage-gated Ca2þ channel) and
Otof knockout mice that also bear severe hair cell synapto-
pathies.9,30,44 Given the selective sensory deﬁcit, it was
possible to test the stability of the ‘‘silent’’ glutamatergic
synapses. Strikingly, synaptic morphology in IHCs wasThe Ameastonishingly well maintained up into adulthood of the
animals. We found mostly normal active zones and only
a small number of atypical ribbons at age 3 months in mu-
tant and wild-type IHCs, in contrast to the predominantly
thin and elongated ribbons described in 3-week-old
Slc17a8/ mice by Seal and collaborators.12 The apparent
discrepancy in these ﬁndings, however, may be explained
by the differences in the genetic background. The mice in
the present study were obtained by crossing heterozygous
129/Sv and C57BL/6 mice, whereas the Slc17a8/ mice
studied by Seal et al.12 were derived solely from C57BL/6
mice, a strain prone to age-related hearing loss.45 We
were also unable to show any statistical difference in the
number of vesicles per ribbon, in contrast to Obholzer
et al.,46 who showed a reduction in vesicle number in
Slc17a8 mutant zebraﬁsh. However, the larger size and
spherical shape of the zebraﬁsh synaptic ribbon and the
higher number of tethered synaptic vesicles may have
permitted a more precise quantiﬁcation in this model as
compared to the mouse.
Because glutamate has been shown to provide trophic
support for spiral-ganglion neurons,47 the deﬁciency of af-
ferent synapses we observed is probably due to the lack of
neurotransmitter release, which in turn leads to secondaryrican Journal of Human Genetics 83, 278–292, August 8, 2008 289
degeneration of postsynaptic spiral-ganglion neurons. The
neuronal loss in the spiral ganglion wasmilder than that of
the CaV1.3 and Otof mutants, in which stimulus-secretion
coupling is blocked at the level of Ca2þ inﬂux or vesicle fu-
sion. These ﬁndings raise the fascinating possibility that
synapses and spiral-ganglion neurons of Slc17a8 knockout
mice are better maintained because of functional secretion
of trophic factors such as neurotrophin 3 (MIM 162660).48
This hypothesis and the possibility of release of other neu-
roactive substances from Slc17a8-deﬁcient IHCs remain to
be tested in future studies.
The signiﬁcant reduction of lateral efferent endings be-
low IHCs is difﬁcult to interpret because their fate has not
been investigated in other mutant mice lacking neuro-
transmitter release (e.g., Bassoon and Otoferlin). During
development, Vglut3 is heavily expressed in GABA/glyci-
nergic cell bodies and terminals of brainstem auditory
nuclei, particularly the lateral superior olive, which
contains the lateral efferent cell bodies.49–51 It may be
possible that the absence of Slc17a8 expression during
this period has resulted in a disruption of the auditory
brainstem circuitry, leading to a secondary loss of lateral
efferent neurons. Alternatively, the lack of input activity
to the lateral superior olive may have caused this efferent
neuron loss.
Impairment of VGLUT3 Causes Nonsyndromic
Deafness DFNA25
Age-related hearing impairment is the most common sen-
sory disorder in older individuals, with an incidence of up
to 80% by the seventh decade of life. Both genetic factors
and environmental factors such as noise exposure inﬂu-
ence the development of presbycusis.2,33 Although many
genes responsible for hereditary hearing impairment
have been identiﬁed,4 SLC17A8 in particular may be
a good candidate gene or locus for presbycusis. Like presby-
cusis, the DFNA25 phenotype is one of autosomal-domi-
nant hearing loss with penetrance that increases with age
and preferentially affects high frequencies. Because
DFNA25 mutation carriers develop deafness despite the
presence of the normal protein, and Slc17a8þ/ mice
have normal hearing responses and normal anatomy, hap-
loinsufﬁciency does not appear to be a likely explanation
of deafness due to the p.A211V mutation.
The demonstration of normal electrically evoked ABRs
in Slc17a8/ knockout mice suggests that cochlear im-
plantation may be of beneﬁt for patients with a deﬁciency
of SLC17A8 deafness, especially if any with homozygous
inactivating mutations are found. To our knowledge, no
hearing-impaired member of either family 1 or family
1490 has undergone cochlear implantation. There is a crit-
ical period in which electrical stimulation by a cochlear
implant will maintain the viability of spiral ganglion neu-
rons despite a defective organ of Corti (reviewed in Roehm
and Hansen52). Consequently, further investigations of
the role of SLC17A8 may be helpful to understand the
pathogenesis of and develop therapies for nonsyndromic290 The American Journal of Human Genetics 83, 278–292, Augustdeafness DFNA25, as well as to further elucidate the molec-
ular mechanisms of the IHC afferent synapse.
The absence of the p.A211V mutation in controls and
conservation of the A211 residue across species does not
exclude the possibility that it is a benign polymorphism.
The most convincing evidence that a mutation is patho-
logic rather than a benign polymorphism is identifying
more than one mutation in the same gene in unrelated
individuals of similar phenotype.53 Although one could
argue that family 1490 is the same family as family 1, given
that the exact samemutation was found, the small block of
linkage disequilibrium suggests that the two families are
no more closely related than any two in the general popu-
lation. Because there is no other linked family available to
narrow the large DFNA25 interval, we cannot rule out the
possibility that a mutation in a different gene or genes
explains the deafness in these families. Further character-
ization of the effects of the p.A211V mutation in ex-
perimental animals and assaying additional families for
mutations in SLC17A8 may provide further evidence.
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